Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
.10 isn't very far away in the grand scheme of things.
Numbers will definitely be interesting.
Favs did $8M in revenue and they inked their agreement April 3. So that's literally 1 month.
Favs made up 36% of the overall revenue for the quarter.
If we assumed everything stayed equal, no growth, just same sales, 3 months of Favs would be $24M.
If that $24M stays at 36%, then the overall revenue for the quarter would have to be around $67M.
I think the market is sleeping on KAVL. I think we need another Q under our belt for it to really begin to shine. We shall see!
Still seems very quiet too. Same names posting, just need to get more eyes and we'll be golden!
Nice hod close. Looking forward to one of those 50-100% candles
Just to make it easier on folks...
https://www.avosinamed.com/solutions/#Telemedicine
Telemedicine Platform powered by CareClix
I reached out to the company just telling them not to forget their shareholders.
I've been keeping in contact with the T/A since early August. This is the change in the unrestricted which probably has something to do with the share price falling a bit.
2/28/2020 - 33,648,610
5/27/2020 - There was no change in O/S, so I'm assuming unrestricted was the same also.
8/7/2020 - 34,228,872 +580,262
8/25/2020 - 34,386,517 +157,645
9/1/2020 - 34,716,340 +329,823
9/3/2020 - 34,716,340 +0
So 1,067,730 was added to the float since 2/28/2020. I don't know the reason for it right now but it might be found in the subsequent events of the next quarterly.
Since 8/7 we traded 2.5M shares.
So per the email I received a little bit ago it does seem that they are submitting.
Additionally, I see KAVL hired someone to lobby for them. So maybe they are helping fund the application...
https://projects.propublica.org/represent/lobbying/r/301026171
So it seems, as long as we have an application submitted we should be good to continue distributing bidi sticks for at least 1 year.
Yeah, we're not really established yet so from Q to Q we will lose people because they are unsure as to what's going on, if there is growth, etc.
Once we get a few quarters under our belt and they show flat or earnings growth we'll begin to see an actual trend and confidence in the company.
Looking forward to the next earnings! Hopefully soon. Maybe another Friday drop, which wouldn't be the best timing due to the 3 day weekend, but on the flip side if it showed massive revenue, I don't think it being Friday matters.
I think KAVL is set up so that if anything were to happen to Bidi Vapor, whether FDA related, or lawsuit related, KAVL, the shareholders, etc would not be held responsible for any wrong doing. KAVL is all about the distribution channels, so even if Bidi Sticks go away, our CEO can set up a new company, produce a new product and utilize the KAVL distribution network.
The only way we, as in KAVL, can remain safe and not liable for Bidi Vapor, despite having the same CEO, is by keeping the entities completely separate. Failing to keep the entities separate will result in piercing the corporate veil and in the end will bring down both KAVL and Bidi Vapor.
I think this way because our CEO has numerous businesses with all different types of products. CBD, CBD drinks, etc. Again, the only reason to keep them all separate is to avoid liability. If a bad CBD product comes out and kills people, it's not going to hit KAVL, or Bidi Vapor, etc, because it's related to the CBD company.
I believe that if KAVL were to pay for anything FDA related, it would result in piercing the corporate veil and opening up the entire company to liability. Bidi Stick is not KAVL's product thus we shouldn't care about it's financials. Obviously we do somewhat care since if they aren't profitable, who knows how long they will continue in business, but that's not the point of what I'm saying.
Dilution.
No worries. Anything we can all bring to the table helps.
This is an email I received in June when I discovered that PDF being sent to our CEO (Although company was Bidi Vapor not KAVL). It makes me believe it's not on KAVL.
No company has been approved by the PMTA yet, as the actual PMTA submissions are due September 9, 2020. Then the FDA will begin their review and approval process of all accepted applications. The BIDI Vapor application is on track and we have full confidence in the strength of their application, and where BIDI stands for future approval.
Thanks again for being a valued shareholder!
Again, I'm not sure why KAVL would be liable for the FDA fees.
It's Bidi Stick's responsibility.
Tough call for sure.
I do see that some shares have been added to the unrestricted which although it isn't much, doesn't help when we have minimal volume like we've had.
I think it's just low volume antics and lack of patience.
Once we see the quarterly results we'll have a better idea of what's going on. If we see growth, then investors will take notice. We aren't too far away from filings!
Just a retest of 20day. Looks good and hopefully clears up some of the overhead shares.
Yeah gonna hit some radars, then people will come to the board and see the weak pump you and your crew are providing.
Then they'll see how the company added 130M to the o/s in a few months.
Seems like low volume nonsense.
Unfortunately personal timelines rarely align with the big moves. So you see slow drops like this until the next catalyst.
The company looks and feels like the real deal, a true future Nasdaq stock, the only problem right now is we've only seen one quarter of results. Was that a great quarter, was it a bad quarter? What can we expect quarter over quarter, what kind of growth trajectory is the company on.
We can put some puzzle pieces together based on the first Q, the websites, the distributors, the non-US websites popping up, but we need more history before these quiet periods move upwards, not downwards.
I think patience pays off, and we'll see!
I sent an email to the email on the otc website, we'll see if I get a response.
I have reasoning to be long, you have reasons to not be. It would be nice if that was the end of the conversation, except it never is.
Agreed. Nothing is guaranteed down here. Just gotta place your bets and let things unfold, or bail.
I still have faith when we get off the greys and release financials that we'll see stock appreciation.
TDOC just merged with Livingo for a 50x their 2020 estimated revenue.
That number is massive. SOLI in it's first Quarter did $500k in revenue. That is 2M a year and a 50x multiple puts it up at $100M market cap which is right around a share price of .50.
Now imagine if we're only doing 1M a quarter, 4M a year 50x multiple = 200M valuation, or $1/share.
$1M still seems very low for a company that seems to be constantly growing. so $2M quarter/8M year, 50x multiple = 400M valuation and $2 share price.
I still think these numbers are low, but it shows how hot the sector is and .30s will be long gone when we see financials.
OTC Markets has been updated but Market Cap seems to still be referencing the old O/S.
It looks like some shares are hitting the unrestricted #. Not sure who/what it could be for, but with minimal volume it seems to be dragging us down a bit.
OTCmarkets has been updated with our new O/S, but Market Cap still too high.
Filled, only took 6 minutes.
This stock intrigues me. That random volume last week, holding up fairly well still. I put in an order at the ask, and it hasn't filled yet.
I get the frustration. I think we are all a bit peeved, especially with how well we were moving until the suspension.
I still think that suspension was unwarranted. The title of the PR was risky, but if anyone read the actual PR it was very clear they weren't selling test kits but with the ever changing rulings, it was probably not the best idea to release.
What we see is a company that continues to add new employees, that continues to be utilized by various companies, and that continues to show up in articles all over the web.
Anyone holding here is betting on the future. So the question is, what happens when we're off the greys. Based on the DD posted, do you expect revenues to have grown? What happens when we're off the greys and we file for our name change to CareClix? If you believe, then it's a perfect time to add. If you don't believe, then hope things turn out great or bail your shares.
Oh so now you're comparing SOLI to IBM or AAPL? Large accelerated filers vs a smaller growth/emerging company.
We don't know what is going on, but I don't know why you think you're privy to that information.
Yes a tweet or PR would be nice with an explanation as to what the hold up is, but again, they are trying to get off the greys, so why jeopardize with saying anything to anyone.
For all we know the old accounting firm screwed the pooch on the financials and the new firm had to start from scratch. We knew the merger/buy out last year caused a very slow turn around in filings so maybe mistakes were made and now are being cleaned up.
The company has their own timeline and some here, even non shareholders, can't fathom why a company won't give them inside information. Penny stock mentality.
Why so secretive?
Because providing information to me, to you, to anyone on a solo basis is considered inside information. Do you really want them to provide YOU with information so that you can make investment/trading decisions based on that?
Well I'm sure you would, but they are looking to get off the greys, not be forever banned to them.
Good luck elvis. I hope you get all the answers you're looking for.
6 weeks is debatable, I'd say closer to 3-4 weeks because the agreements weren't signed until early April unless they were doing business before agreements were signed.
On May 21, 2020, we entered into an A&R Sub-Distribution Agreement with Favs Business, LLC (“Favs”), which amended and restated that certain Non-Exclusive Sub-Distribution Agreement, dated April 3, 2020, previously entered into by Favs and us
I don't think the FDA compliance is on the shoulders of KAVL so the net profit should not be impacted by any FDA expenses. We are just the brand builders/distributors.
The below letter was sent to our CEO, but under Bidi Vapor, not Kaival.
https://www.fda.gov/media/139075/download
Lol, I remember that.
No one said a word, and I'm like ummmm guys, we had $22.5M revenue! WHY ISN'T ANYONE LOOKING AT THIS.
Then some folks were making jokes about this going down, and needless to say .07 hasn't showed up since.
Good times!
Looks awesome still for sure.
This candle looks a lot like the one right around .50 eh? :p
They have responded to me a few times. Nothing that I needed to keep hush hush.
But if they see the same message from a handful of us they may do it.
I emailed IR and told them they need to update OTC markets. It's not a huge deal, but maybe a few others can also reach out and let them know.
Yeah, all $250 lol
Maybe your rent is due?
Should hit some scanners. Chart looks great.